<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3">
 <label>3</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Motzer</surname>
    <given-names>RJ</given-names>
   </name>
   <name>
    <surname>Escudier</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>McDermott</surname>
    <given-names>DF</given-names>
   </name>
   <name>
    <surname>George</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Hammers</surname>
    <given-names>HJ</given-names>
   </name>
   <name>
    <surname>Srinivas</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma</article-title>. 
  <source>N Engl J Med</source> (
  <year>2015</year>) 
  <volume>373</volume>(
  <issue>19</issue>):
  <page-range>1803â€“13</page-range>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1510665</pub-id>
 </mixed-citation>
</ref>
